Assisted reproductive technologies
Adult: As acetate: equiv to 0.25 mg cetrorelix either in the morning beginning on the day 5 or 6 of ovarian stimulation or in the evening beginning on day 5, and continued until ovulation induction. Alternatively, a single dose equiv to 3 mg cetrorelix on day 7,; if follicle growth does not allow ovulation induction within 4 days, additional doses of 250 mcg once daily may be given until the day of ovulation induction.
Hypersensitivity. Moderate to severe renal or hepatic impairment. Women with severe allergic conditions. Pregnancy and lactation;
Warnings / Precautions
Women with active allergic conditions or a history of allergies; childn; elderly >65 yrs
Adverse Reactions
Mild and transient reactions at Inj site, nausea, headache, ovarian hyperstimulation syndrome, systemic hypersensitivity reactions.
Lab Interactions
Increased ALT, AST, GGT and alkaline phosphatase.
Mechanism of Actions
Cetrorelix, a synthetic decapeptide analog of naturally occurring gonadorelin, is a gonadorelin antagonist. It competitively blocks gonadorelin receptors on the anterior piyuitary gonadotroph and the subsequent transduction pathway, inducing a rapid, reversible suppression of gonadotrophin secretion.
Duration: 4 days for a single 3-mg dose.
ATC Classification
H01CC02 - cetrorelix ; Belongs to the class of anti-gonadotropin-releasing hormones. Used in hypothalamic hormone preparations.
Available As
  • Cetrorelix 0.25 mg
  • Subscribe for latest updates

    Subscribe to our e-mail newsletter to receive updates.

    No comments yet.

    Post Review about Cetrorelix

    Cetrorelix Containing Brands

    We are Developing Our database, More results coming soon.

    Cetrorelix is used in following diseases

    We are Developing Our database, More results coming soon.

    Drug - Drug Interactions of Cetrorelix

    We are Developing Our database, More results coming soon.